CervoMed Inc. Quarterly Debt-to-equity in % from Q3 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CervoMed Inc. quarterly Debt-to-equity history and growth rate from Q3 2016 to Q3 2024.
  • CervoMed Inc. Debt-to-equity for the quarter ending September 30, 2024 was 10.8 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 10.8 +45.3 Sep 30, 2024
Q2 2024 15.1 Jun 30, 2024
Q1 2024 -171 Mar 31, 2024
Q4 2023 -41.2 Dec 31, 2023
Q3 2023 -34.5 Sep 30, 2023
Q4 2021 6.1 -5.77 -48.6% Dec 31, 2021
Q3 2021 6.46 -7.03 -52.1% Sep 30, 2021
Q2 2021 7.13 -8.18 -53.4% Jun 30, 2021
Q1 2021 8.42 -10.1 -54.6% Mar 31, 2021
Q4 2020 11.9 -7.94 -40.1% Dec 31, 2020
Q3 2020 13.5 -5.48 -28.9% Sep 30, 2020
Q2 2020 15.3 -1.54 -9.14% Jun 30, 2020
Q1 2020 18.6 +4.28 +30% Mar 31, 2020
Q4 2019 19.8 +7.45 +60.2% Dec 31, 2019
Q3 2019 19 +4.96 +35.4% Sep 30, 2019
Q2 2019 16.9 -22.4 -57% Jun 30, 2019
Q1 2019 14.3 -93.9 -86.8% Mar 31, 2019
Q4 2018 12.4 -1.18K -99% Dec 31, 2018
Q3 2018 14 +4.93K Sep 30, 2018
Q2 2018 39.2 -3.79K -99% Jun 30, 2018
Q1 2018 108 -387 -78.2% Mar 31, 2018
Q4 2017 1.19K +1.14K +2081% Dec 31, 2017
Q3 2017 -4.92K -4.97K -9455% Sep 30, 2017
Q2 2017 3.83K Jun 30, 2017
Q1 2017 495 Mar 31, 2017
Q4 2016 54.8 Dec 31, 2016
Q3 2016 52.6 Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.